Transparency Market Research (TMR) has published a new
report titled, ‘Antithrombin
Treatment Market - Global Industry Analysis, Size, Share,
Growth, Trends, and Forecast, 2019–2027’. According to the report, the global
antithrombin treatment market was valued at US$ 0.50 Bn in 2018 and is
projected to expand at a CAGR of 5.3% from 2019 to 2027.
Overview
·
Antithrombotic drugs help in the
prevention or inhibition of thrombus by mimicking the role of antithrombin, a
protein molecule produced in the body, which helps in clotting. Antithrombin is
a small protein involved in the inactivation of several enzymes in the
coagulation system. It is used in several medical treatments such as hereditary
antithrombin deficiency, ECMO, DIC, and sepsis. Engineered recombinant
antithrombin has gained clinical significance in recent years for the
prevention of various peripartum and perioperative thromboembolic events or
blood clots.
·
The antithrombin treatment market is
currently a booming one, due to rise in awareness and acceptance of
antithrombin therapy in proven applications and adoption of medical conditions
such as hereditary antithrombin deficiency, and prevention of various
peripartum and perioperative thromboembolic events or blood clots, ECMO, DIC,
and sepsis. Moreover, increasing use in combination therapy of antithrombin
with heparin is likely to further support the growth of the market.
·
North America dominate the global
antithrombin treatment market in 2018 and the trend is anticipated to continue
during the forecast period. Early adoption of advaced therapies and well
established healthcare infrastructure accentuate antithrombin treatment market
growth in the region.
·
Asia Pacific is likely to be a highly
lucrative market for the antithrombin treatment market and it is expected to
expand at a high CAGR during the forecast period. Rise in demand of therapeutic
antithrombin, low pricing pressure, increasing healthcare expenditure are key
factors likely to boost antithrombin treatment market in Asia Pacific.
Request a PDF Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4500
Exploring Use of Antithrombin
Products to Drive Global Antithrombin Treatment Market
·
Antithrombotic drugs act by imitating
antithrombin protein, molecule which is produced by liver and is involved in
clotting and thus support in the prevention or inhibition of thrombus.
Antithrombin protein molecule is synthesized by the liver, and along with other
benefits, it has coagulant effects.
·
Engineered recombinant antithrombin has
gained clinical significant in recent years for the prevention of various
peri-partum and peri-operative thromboembolic events or blood clots.
·
Discovering new indications over the
existing ones will create gigantic opportunity with rising demand during the
forecast period. For instance. In Feb 2014, rEVO Biologics Inc. submitted IND
application for ATryn for the treatment of preeclampsia with the USFDA
·
Exploring new applications of
antithrombin products drive the growth of global antithrombin market.
Request a Sample of Antithrombin
Market: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4500
Therapeutic Segment to Dominate Antithrombin
Treatment Market
·
In terms of application, the global
antithrombin treatment market has been segmented into therapeutic, research and
diagnostics. Therapeutic segment is dominate the market and is continue its
dominance during the forecast period. Increasing use of antithrombin therapy as
an anticoagulant for the prevention of clots before, during, or after surgery
or birthing in patients with hereditary antithrombin deficiency is projected to
support the growth of the segment during the forecast period
Human Segment Hold a Major Share
of Global Antithrombin Treatment Market
·
In terms of source, the global
antithrombin treatment market has been classified into human, goat milk and
others.
·
The human segment dominated the
antithrombin treatment market. Rising investments in protein therapeutics used
in rare disease by large pharma companies are likely to boost the segment
during the forecast period
Request for Analysis of COVID19 Impact on
Antithrombin Market- https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=4500
Lyophilized Segment to Dominate
Global Antithrombin Treatment Market
·
Based on dosage form, the global
antithrombin treatment market has been segmented into lyophilized and liquid.
Availability of lyophilized antithrombin therapeutic products is a major factor
that drives the segment. Stability of this dosage form in therapeutic
preparations is contribute to increase use of lyophilized dosage form and
thereby drive the growth of segment
North America to Dominate Global
Antithrombin Treatment Market
·
In terms of region, the global
antithrombin treatment market has been segmented into North America, Europe,
Asia Pacific, Latin America, and Middle East & Africa. North America
dominated the global antithrombin treatment market in 2018, followed by Europe.
·
North America accounted for major
share of the global antithrombin treatment market in 2018. Supportive
healthcare and payer infrastructure, and hub for key industry players are the
major drivers of the antithrombin treatment market in the region.
·
The antithrombin treatment market in
Asia Pacific is anticipated to expand at a high CAGR from 2019 to 2027. The
rapidly rising population with prevalence hereditary antithrombin deficiency in
countries such as India and China provide large market for antithrombin
therapy.
Buy now
Antithrombin Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=4500<ype=S
Competitive Landscape
·
The global antithrombin treatment
market is fragmented in terms of number of players. Key players in the global
antithrombin treatment market include rEVO Biologics, Inc., Grifols,
Shire plc., CSL Limited, Kedrion S.p.A, Octapharma AG, Dem ilac Inc., Lee
Bisolutions, Diapharma and Scripps Laboratories, Inc
More Trending Reports by
Transparency Market Research:
https://www.prnewswire.co.uk/news-releases/sizeable-numbers-to-endorse-benefits-and-efficacy-of-umbrella-of-hormone-replacement-therapies-underscores-growth-in-testosterone-replacement-therapy-market-valuation-projected-to-touch-us-2-2-bn-by-2027-says-tmr-819153496.html
https://www.prnewswire.com/news-releases/rapidly-ageing-global-population-to-present-abundant-growth-opportunities-for-the-cerebral-somatic-oximeters-market-rise-in-hypoxic-ischemic-encephalopathy-to-boost-demand-in-the-market-tmr-301260665.html
About Us
Transparency Market Research is a global market intelligence
company, providing global business information reports and services. Our
exclusive blend of quantitative forecasting and trends analysis provides
forward-looking insight for thousands of decision makers. Our experienced team
of analysts, researchers, and consultants, uses proprietary data sources and
various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team
of research experts, so that it always reflects the latest trends and
information. With a broad research and analysis capability, Transparency Market
Research employs rigorous primary and secondary research techniques in
developing distinctive data sets and research material for business reports.
Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com/
